Apparently the IPO filing hiatus isn’t entirely a dead end story. A company called AutoGenomics, Inc. has filed a registration statement for a proposed initial public offering. It has applied for the ticker "AGMX" on NASDAQ.
The share count and the pricing of this IPO are not yet determined, but it listed the "up to"amount as $86.3 million for filing purposes. All shares in the offering will be sold by the company rather than insiders.
The company lists J.P. Morgan Securities as the sole book-runner andalso lists Deutsche Bank Securities as co-lead manager. Co-managersare listed as Pacific Growth Equities and Robert W. Baird & Co.
The company designs, develops, manufactures and markets a fullyintegrated molecular diagnostics system called the INFINITI™ thatautomates the discrete processes of genetic testing performed byclinical laboratories. It already holds trademarks of INFINITI™,BioFilmChip™, Intellipac™ and Qmatic™, and it received market approvalfrom the FDA for its INFINITI™ system.
Jon C. Ogg
July 25, 2008
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
